ReviewDigital health
Innovative technological resources for Alzheimer's disease care management: A scoping review.
Review in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this scoping review was to map and describe the technological tools reported in the literature that have been designed for care management in Alzheimer's disease, with a particular focus on supporting patients living with the condition, their families, caregivers, and healthcare professionals. Methods: The review was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) framework. A comprehensive literature search was performed across multiple databases, including Scopus, PubMed, Web of Science, and CINAHL, focusing on studies addressing technological resources aimed at supporting the care and management of Alzheimer's disease. Results: A total of 23 studies were included in the final analysis. The most frequently utilized technologies were mobile applications and wearable devices. The most identified functionalities included cognitive training, location tracking, task reminders, communication support, fall detection, and vital signs monitoring, often integrated into comprehensive solutions to enhance patient care and safety. Conclusion: Overall, these technologies were designed to support both patients and caregivers. However, despite the clear benefits and innovative potential of these technologies, significant limitations remain, particularly the lack of empirical validation in real-world clinical settings and the need to ensure greater usability for older adults and individuals with cognitive impairments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.